CBD Life Sciences Inc. (CBDL) Launches First-of-Its-Kind Mushroom-Infused "Dubai Chocolate Bar"
CBD Life Sciences (OTC PINK:CBDL) announced the launch of a Mushroom-Infused Dubai Chocolate Bar through its subsidiary CBD Vault on October 21, 2025. The premium bar blends pistachio-filled Dubai-style chocolate with Cordyceps and Reishi extracts, positioning the company at the intersection of luxury confectionery and functional wellness.
The release cites the Dubai chocolate market > $1.5 billion with a 6.8% annual growth rate and a projected $35 billion global functional mushroom market by 2030 (CAGR 10.8%). CBDL says it will add the product to its Mushroom Madness line and pursue international and domestic distribution, expecting recurring revenue in Q4 2025 and through 2026.
CBD Life Sciences (OTC PINK:CBDL) ha annunciato il lancio di una barretta al cioccolato di Dubai infusa di funghi tramite la controllata CBD Vault il 21 ottobre 2025. La barre premium combina cioccolato in stile Dubai ripieno di pistacchio con estratti di Cordyceps e Reishi, posizionando l'azienda all'incrocio tra confetteria di lusso e benessere funzionale.
Il comunicato cita che il mercato del cioccolato di Dubai > $1,5 miliardi con una crescita annua del 6,8% e un mercato globale dei funghi funzionali proiettato a $35 miliardi entro il 2030 (CAGR 10,8%). CBDL afferma che aggiungerà il prodotto alla linea Mushroom Madness e cercherà distribuzione internazionale e domestica, prevedendo ricavi ricorrenti nel Q4 2025 e nel 2026.
CBD Life Sciences (OTC PINK:CBDL) anunció el lanzamiento de una barra de chocolate de Dubai infusionada con hongos a través de su filial CBD Vault el 21 de octubre de 2025. La barra premium fusiona chocolate al estilo Dubai relleno de pistacho con extractos de Cordyceps y Reishi, posicionando a la compañía en la intersección de la confitería de lujo y el bienestar funcional.
El comunicado cita que el mercado de chocolate de Dubai > $1.5 mil millones con una tasa de crecimiento anual del 6.8% y un mercado global de hongos funcionales proyectado de $35 mil millones para 2030 (CAGR 10.8%). CBDL dice que agregará el producto a su línea Mushroom Madness y buscará distribución internacional y doméstica, esperando ingresos recurrentes en Q4 2025 y a lo largo de 2026.
CBD Life Sciences (OTC PINK:CBDL)는 자회사 CBD Vault를 통해 2025년 10월 21일에 버섯을 주입한 두바이 초콜릿 바를 출시했다고 발표했습니다. 이 고급 바는 피스타치오로 채운 두바이식 초콜릿과 Cordyceps 및 Reishi 추출물을 혼합하여 고급 과자와 기능성 웰빙의 교차점에 회사를 위치시키고 있습니다.
발표에 따르면 두바이의 초콜릿 시장 > $15억과 연간 성장률 6.8%, 그리고 2030년까지 글로벌 기능성 버섯 시장이 $350억 규모로 예측되며 CAGR은 10.8%로 예상됩니다. CBDL은 이 제품을 Mushroom Madness 라인에 추가하고 국제 및 국내 유통을 추진하며 2025년 4분기에 반복 수익을 기대하고 2026년까지 이어질 것이라고 말합니다.
CBD Life Sciences (OTC PINK:CBDL) a annoncé le lancement d'une barre de chocolat de Dubai infusée de champignons via sa filiale CBD Vault le 21 octobre 2025. La barre premium associe le chocolat de style Dubai garni de pistache avec des extraits de Cordyceps et Reishi, positionnant la société à l'intersection de la confiserie de luxe et du bien-être fonctionnel.
Le communiqué mentionne que le marché du chocolat de Dubai > 1,5 milliard de dollars avec un taux de croissance annuel de 6,8% et un marché mondial des champignons fonctionnels projeté à 35 milliards de dollars d'ici 2030 (TCAC 10,8%). CBDL dit qu'ajoutera le produit à sa ligne Mushroom Madness et poursuivra une distribution internationale et nationale, en prévoyant des revenus récurrents dès Q4 2025 et jusqu'en 2026.
CBD Life Sciences (OTC PINK:CBDL) kündigte den Start einer Mushroom-Infused Dubai Chocolate Bar durch seine Tochtergesellschaft CBD Vault am 21. Oktober 2025 an. Die Premium-Bar vereint pistaziengefüllte Dubai-Stil Schokolade mit Cordyceps und Reishi-Extrakten und positioniert das Unternehmen am Schnittpunkt von Luxuskonfekt und funktionalem Wohlbefinden.
Die Mitteilung verweist auf den Dubai-Schokoladenmarkt > 1,5 Milliarden mit einer jährlichen Wachstumsrate von 6,8% und einen prognostizierten weltweiten Markt für funktionelle Pilze von 35 Milliarden US-Dollar bis 2030 (CAGR 10,8%). CBDL sagt, es werde das Produkt zur Mushroom Madness-Linie hinzufügen und sowohl internationale als auch inländische Distribution verfolgen, wobei wiederkehrende Einnahmen in Q4 2025 und bis 2026 erwartet werden.
CBD Life Sciences (OTC PINK:CBDL) أعلنت عن إطلاق شوكولاتة دبي الممزوجة بالفطر عبر فرعها CBD Vault في 21 أكتوبر 2025. القطعة الفاخرة تجمع شوكولاتة دبي بأسلوب دبي المحشوة بالفستق مع مستخلصات Cordyceps و Reishi، مما يضع الشركة عند تقاطع الحلويات الفاخرة والرفاهية الوظيفية.
تشير البيان إلى أن سوق شوكولاتة دبي > 1.5 مليار دولار بمعدل نمو سنوي 6.8% وأن سوق الفطر الوظيفي العالمي المتوقع بحلول 2030 هو 35 مليار دولار (CAGR 10.8%). تقول CBDL إنها ستضيف المنتج إلى خط Mushroom Madness وستسعى لتوزيع دولي ومحلي، مع إيرادات متكررة في الربع الرابع من 2025 وخلال 2026.
CBD Life Sciences (OTC PINK:CBDL) 通过其子公司 CBD Vault 于 2025年10月21日 宣布推出蘑菇注入的迪拜巧克力棒。该高端巧克力将迪拜风格的开心果夹心巧克力与 Cordyceps 与 Reishi 提取物相结合,将公司定位在豪华糖果与功能性健康的交汇点。
公告称,迪拜巧克力市场 > 15亿美元,年增长率为 6.8%,全球功能性蘑菇市场到 2030年 的预测规模为 350亿美元(CAGR 10.8%)。CBDL 表示将把该产品加入 Mushroom Madness 系列,并推动国际与国内分销,预计在 2025年第四季度 的重复性收入以及 2026年 实现。
- Dubai chocolate market > $1.5B with 6.8% annual growth
- Functional mushroom market forecast $35B by 2030 (10.8% CAGR)
- Product launch targets recurring revenue in Q4 2025 and through 2026
- None.
Dubai's luxury chocolate market-valued at over
SCOTTSDALE, ARIZONA / ACCESS Newswire / October 21, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), through its wholly owned subsidiary CBD Vault, is proud to announce the official launch of its Mushroom-Infused Dubai Chocolate Bar, a premium fusion of functional wellness and luxury indulgence.
Inspired by the decadent chocolate culture of Dubai, each bar combines pistachio-filled layers with rich, velvety chocolate and is infused with Cordyceps and Reishi mushroom extracts, two of the most powerful adaptogens known to enhance focus, immunity, and stamina. This marks one of the first products in the world to successfully merge functional mushrooms with Dubai-style luxury confectionery, placing CBDL at the forefront of a rapidly evolving edible wellness revolution.
A Billion-Dollar Intersection of Wellness and Luxury
The Dubai chocolate market alone generates more than
By strategically combining these two sectors, CBDL is positioning itself for exponential growth, introducing a new revenue vertical that blends wellness benefits, cultural sophistication, and mass appeal.
A Game-Changing Product for CBDL's Expansion
"We wanted to bring something extraordinary to the table-a product that tastes world-class and performs like a supplement," said a CBDL spokesperson. "By infusing our signature mushroom blend into a pistachio-filled Dubai-style chocolate bar, we're creating not just a treat but a wellness experience. This product can open doors across luxury retail, health stores, airports, and online marketplaces, while significantly enhancing shareholder value."
CBD Life Sciences plans to integrate the Mushroom-Infused Dubai Chocolate Bar into its Mushroom Madness product line and will pursue distribution through both international wellness chains and domestic retail partners. The company believes this launch could drive strong recurring revenue in Q4 2025 and throughout 2026, as the brand expands its footprint across the luxury wellness market.

About CBD Life Sciences Inc. (CBDL)
CBD Life Sciences Inc. (OTC PINK: CBDL) is a publicly traded company specializing in cutting-edge wellness innovations, offering a wide range of CBD, functional mushroom, and plant-based products under its flagship brand, CBD Vault. The company remains committed to science-driven formulation, sustainable sourcing, and rapid expansion through retail and e-commerce channels across North America and beyond.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
Website: https://www.thecbdvault.com
IR Contact: cbdvaultaz@gmail.com
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences, Inc.
View the original press release on ACCESS Newswire